Publications
Specialty
Search
EMSWorld
06/06/2024
Through this agreement, Technimount EMS is pleased to introduce to the Canadian market the Abdominal Aortic and Junctional Tourniquet–Stabilized (AAJT-S), a multi-purpose life-saving device to stop massive bleeding in the junctional regions of the body and pelvis in emergency, military, and hospital settings.
The Dermatologist
06/06/2024
What do students and mentors need to know to stay above water? This article spotlights the ongoing debates regarding dermatology residency applications and suggests a path forward for students and their mentors.
Pharmacy Learning Network
06/06/2024
Metal found in a tablet has prompted Rubicon Research Private Limited to recall 11,664 bottles of metoprolol tartrate.
Advances in Inflammatory Bowel Disease Network
06/06/2024
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
First Report Managed Care
06/05/2024
A phase 3 study evaluated the efficacy and safety of fitusiran in males with hemophilia A or B who were receiving bypassing agent (BPA)/clotting factor concentrate (CFC) prophylaxis.
Pharmacy Learning Network
06/05/2024
ARG Laboratories Inc. is recalling a handful of over-the-counter pain-relieving creams and protective sunscreens for being out of specification for active ingredients.
Wound Care
06/05/2024
CMS released 4 new A codes at the First CMS Biannual 2024 HCPCS Public Meeting including xenoPatch (manufactured by DSM) for Extremity Care, MatriDerm (manufactured by MedSkin) for Access Medical, MicroMatrix Flex for Integra, and MiroTract Wound Matrix for Reprise Biomedical.
Wound Care
06/05/2024
A retrospective 134-patient study compared the use of polyhexamethylene biguanide and betaine (PHMB-B) vs saline when used as the install solution in NPWT for diabetic foot infections (DFIs) and found no difference in length of stay, cost of hospitalization, or application times. Sci Rep
Wound Care
06/05/2024
In May 2024, BioMonde was awarded a share of ~$1.1MM (£900k) of funding support from the Welsh government-backed SMART FIS program. The funding will be used to develop products from larval secretions.
Wound Care
06/05/2024
Avita Medical announced the FDA has approved its premarket approval for the RECELL GO System, a next-generation autologous cell harvesting device for treating thermal burn wounds and full-thickness skin defects. The company plans to launch in top burn treatment centers throughout the US.
Wound Care
06/05/2024
A systematic review and meta-analysis of 381 patients found that NPWT was used for an average of 21.2 days and could be a valuable adjuvant therapy for the management of SSI after spine surgery, but more high-quality evidence is needed. Eur J Orthop Surg Traumatol
Wound Care
06/05/2024
An interim analysis of a 50-patient RCT demonstrated a 44% reduction in time for achieving DFU healing when using a novel polylactic acid (PLA) matrix vs a collagen dressing. A significant increase in blood flow and granulation tissue was also observed. SAWC Spring 2024 Poster CR-051
Wound Care
06/05/2024
SmartTRAK noted that the total waiting list for procedures and appointments in the UK remained stable at around 7.54 million in March 2024. The nunmber of people waiting more than 65 weeks dropped by nearly -35% from February to March, while 1-year waits were up by +1.4%.
Wound Care
06/05/2024
A retrospective review of participating Home Health Agencies identified 38,445 wound episodes of which 15% were PUs, 23% surgical wounds, 10% venous/arterial ulcers, 8% diabetic ulcers, and 46% were classified as other. SAWC Spring 2024 Poster CR-43
Rheumatology & Arthritis
06/05/2024
Understanding the specific strengths and weaknesses of imaging modalities such as CT, MRI, and x-ray, is critical for the accurate diagnosis and monitoring of axSpA, a new review concludes.
EMSWorld
06/05/2024
To many pediatric patients, candy and medication, Gatorade and antifreeze, and Tylenol and tic tacs all look the same.
Oncology
06/05/2024
True or False: The FDA’s accelerated approval of lisocabtagene maraleucel for patients with R/R follicular lymphoma was based on results from a primary efficacy population of 94 patients with PET-positive disease at baseline or following bridging therapy, who received the conforming product in the intended dose range, and who had at least 9 months of follow up from first response.
Wounds
06/05/2024
EMSWorld, Emergency & Mobile Medicine
06/05/2024
When it seems things might escalate, your primary intervention should be a calm and understanding demeanor.
EP Lab Digest
06/05/2024
A team of Ochsner Health cardiologists recently published an article in the